To investigate the association between external beam radiotherapy (EBRT) and pleural and peritoneal mesothelioma among long-term (>5 years) solid cancer survivors.
Results:
We observed 300 mesotheliomas (264 pleural; 32 peritoneal; 4 others) among 913,873 patients. EBRT increased the risk of mesothelioma (any site; HR 1.36, 95%CI 1.05-1.76). We observed an increased risk of pleural mesothelioma (HR for EBRT 1.35, 95%CI 1.02-1.78), but we did not find signs of a dose-response relationship (HR for scattered irradiation 1.35; HR for direct irradiation 1.36). On the opposite, only direct peritoneal irradiation was associated with peritoneal mesothelioma (HR 2.13, , particularly for latencies ≥10 years (HR 3.19, . A competing risks analysis revealed that the clinical impact of radiationinduced mesothelioma was limited by the high frequency of competing events. The cumulative incidence function of mesothelioma after 40 years of observation was very low (non-irradiated patients: 0.00031, irradiated patients: 0.00056).
Conclusion:
EBRT is a determinant of mesothelioma. Longer latency periods are associated with higher risks, while the dose-response seems non-linear. The clinical impact of mesothelioma after EBRT for primary solid cancers is very limited. 
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Material and Methods:
Patients with five or less metastases were eligible for this prospective trial. A four-dimensional respiration-correlated CT (4D-CT) was obtained for planning. In metastases with significant motion, a fiducial marker was implanted for dynamic tracking using the gimbaled Vero SBRT system, otherwise an internal target volume (ITV) was defined to encompass the tumor trajectory. ITV-targets were also treated on Vero, unless numbering 4 or more, in which case tomotherapy was used. A dose of 50 Gy in 10 fractions of 5 Gy was prescribed on the 80% isodose line, covering the planning target volume.
Results:
We treated 87 metastases in 44 patients, with colorectal cancer as the most common primary origin (65.9%). Metastatic sites were mainly lung (n= 62) and liver (n=17). Twenty-seven metastases, of which 12 in lung, 14 in liver and 1 in a kidney, were treated with dynamic tracking, the remaining 60 using the ITV-concept. Three patients (7%) experienced grade ≥3 toxicity, of which one with a liver metastasis invading the major bile ducts with grade 5 cholangitis due to bile duct stenosis. After a median followup of 12 months. we report an actuarial one-year local control (LC) of 89% for the whole group (95% CI 77-95%), with corresponding values of 90% and 88% for the metastases irradiated with the ITV-approach and dynamic tracking, respectively. Median progression-free survival reached 6.5 months, one-year overall survival 97%.
Conclusion:
This first clinical trial on Vero dynamic tracking shows favorable efficacy. SBRT with respiratory motion management resulted in a high LC and acceptable toxicity profile in oligometastatic cancer patients. Purpose or Objective: Contrast enhanced radiotherapy (CERT) has already been shown to be a promising antitumor modality capable to overcome some limitation inherent to conventional beam radiotherapy. Depth dose distribution in CERT is characterized by local dose increase in a volume, which incorporates certain amount of a high atomic number element. Photoabsorption of external X-ray radiation by high atomic number elements (such as iodine, gadolinium, gold etc.) leads to absorbed dose enhancement exactly in the region of the element location. Dose increase is caused by emission of short range secondary radiation such as characteristic X-rays, photoelectrons and Auger electrons. Dose enhancement in CERT for particular high atomic number element is strongly dependent on energy spectrum of external radiation. Calculations of many researchers show that significant part of absorbed dose is caused by Augerelectrons especially in the close vicinity (about 1 um) of emitting atom. Because of their extremely short range in water Auger-electrons are not detectable by most dosimetric tools such as ionizing chambers, radiochromic films etc. However ferrosulfate based dosimeters (Fricke dosimeters) can be used to measure total absorbed dose caused by photoabsorption of external X-ray radiation by high atomic number elements.
Poster: Physics track: Basic dosimetry and phantom and detector development
PO-0792 Direct dose measurements in contrast enhanced radiotherapy with iodine and gadolinium
Material and Methods:
Direct dose enhancement was measured for iodine in the chemical form of iopromide (Ultravist 370, Bayer) and gadolinium in the from of gadolinium sulfate (Sigma-Aldrich). Fricke dosimeter solution was prepared by standard procedure described elsewhere.
________________________________________________________________________________
Iopromide and gadolinium sulfate solutions were introduced into standard Fricke dosimeter solution for final concentrations of iodine from 2.5 mg I/ml to 50 mg I/ml and gadolinium from 5 mg Gd/ml to 10 mg Gd/ml. Detection of iron (III) ions was performed with spectrophotometer Varian Cary 50. For measurement of iron (III) ions concentration in the presence of iopromide ammonium tiocianate (Panreac) was used as an indicator because optical spectrum of iopromide interfere with optical spectrum of iron (III) ions. Irradiation of Fricke solutions was performed with 110 kVp Xrays through 3.5 mm Al filter at 0.7 Gy/min dose rate.
Results: Dose enhancement in presence of iodine and gadolinium was expressed as dose enhancement factor (DEF), which is the ratio of absorbed dose value in Fricke water solution containing iodine or gadolinium and in pure Fricke water solution. Measured DEF values and corresponded iodine and gadolinium concentrations are presented in Table. Dose enhancement is proportional to concentration of the element used. DEF value for iodine varies from 1.2±0.1 to 4.8±0.5 for concentration of iodine from 2.5 mg I/ml to 50 mg I/ml respectively.
Conclusion:
A new approach for measuring dose enhancement in CERT was proposed. This method can be used as a routing procedure in experimental and clinical practice of CERT dose measurements.
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The Advanced Markus ionization chamber is useable for measurements at ultra high dose rates K. Petersson Purpose or Objective: The Advanced Markus ionization chamber from PTW (PTW-Freiburg GmbH, Freiburg, Germany) saturates at high dose rates (Ḋ) and/or at a high dose-perpulse (DPP). According to PTW, the ion collection efficiency is ≥ 99% at continuous Ḋ < 375 Gy/s and at DPP < 5.56 mGy. At a source-to-surface distance (SSD) of 50 cm, our prototype linac produces a mean Ḋ of ≈ 500 Gy/s, an instantaneous Ḋ of ≈ 2.5 MGy/s, and a DPP of ≈ 5 Gy (far above the chamber datasheet range). In order to use the Advanced Markus chamber for determining the absorbed dose in these intense radiation conditions, we needed to establish a model of its saturation as the Ḋ/DPP increases.
Material and Methods:
Two independent methods were used to determine the chamber saturation curve. 1) Measurements in a water phantom at different Ḋ/DPP by varying the SSD and the linac gun grid tension (pulse amplitude). The hypothesis was that if the linac output varies with grid tension in a reproducible way and if the grid tension was varied by the same factor for every SSD then the relative change in chamber response with grid tension should be the same for all SSD if not for the chamber saturation. 2) Simultaneous measurements of chamber and Ḋ/DPP independent radiochromic film (Gafchromic™ EBT3, Ashland Inc., Covington, USA), in a solid water phantom (RW3 slabs, PTW) at various Ḋ/DPP.
Results:
The results show how the chamber saturation increases (the ion collection efficiency decreases) as the DPP increases (Figure) . These results also show that the chamber saturation is much more dependent on the DPP than the instantaneous Ḋ, as the ion collection efficiency curves for the different pulse widths (= DPP/instantaneous Ḋ) are only slightly separated when plotted against DPP. A mathematical model of the saturation curves was established by fitting a logistic function (dependent on DPP) to the data points:
Where ks is the saturation (ion recombination) correction factor and where a takes a slightly different value for different instantaneous Ḋ (a = 0.197, 0.192, and 0.184 for pulse widths of 0.5, 1.0, and 1.8 μs, respectively).
Results from subsequent dose measurements at various Ḋ/DPP verified that chamber dose values (corrected by the saturation model) were compatible with film and TLD dose values.
Conclusion:
We present a saturation model for the Advanced Markus ionization chamber, which was based on dose measurements performed in a water phantom as well as simultaneous film and chamber measurements in a solid water phantom, at various Ḋ/DPP. Chamber dose measurements corrected by the saturation model were compared to independent film and TLD dose measurements. These measurements verified that the Advanced Markus ionization chamber does not completely saturate up to DPP values of 10 Gy and can consequently be used for accurate dose measurements (within 5%) in ultra high Ḋ/DPP irradiation conditions, if the chamber saturation model is applied.
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